Alteration of cellular behavior by antisense modulation of mRNA processing

Details for Australian Patent Application No. 2000240366 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Wyatt, Jacqueline R; Manoharan, Muthiah; Crooke, Stanley T.; Bennett, C. Frank; Karras, James G.; McKay, Robert; Freier, Susan M; Monia, Brett P; Baker, Brenda F

Agent FB Rice

Pub. Number AU-B-2000240366

PCT Pub. Number WO01/72765

Filing date 28 March 2000

Wipo publication date 8 October 2001

Acceptance publication date 4 August 2005

International Classifications

C07H 021/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 015/86 Mutation or genetic engineering - Viral vectors

C12N 015/85 Mutation or genetic engineering - for animal cells

A61K 031/70 - Carbohydrates

A01N 043/04 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

4 August 2005 Application Accepted

  Published as AU-B-2000240366

1 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2000240414

2000240363